Hepatitis Delta in Focus: Episode 3 of Answering the Questions on Screening, Diagnosis, and Treatment

In this episode, Nancy Reau, MD, and Heiner Wedemeyer, MD, provide expert insight on HDV management, including:Use of noninvasive imaging or biopsy for staging liver diseaseScreening for hepatocellular carcinomaHBV treatmentRole of comedications (eg, erythropoietin, eltrombopag)Approach to complex cases, such as patients with:Significant fibrosis and low HDV RNA levelsHepatitis delta antibody positivity, but HDV RNA negativityHIV coinfectionDecompensated or recently decompensated cirrhosisFaculty:Nancy Reau, MD<br />Professor of Medicine<br />Chief, Section of Hepatology<br />Associate Director, Solid Organ Transplantation<br />Richard B. Capps Chair of Hepatology<br />Rush University Medical Center<br />Chicago, IllinoisHeiner Wedemeyer, MD<br />Professor and Chairman<br />Department of Gastroenterology, Hepatology and Endocrinology <br />Hannover Medical School<br />Hannover, GermanyLink to full program: <br />http://bit.ly/3yp1Lxf